These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 867358)
21. [How to improve drug information!]. Järhult B Lakartidningen; 1998 Jul; 95(30-31):3278-9. PubMed ID: 9715057 [No Abstract] [Full Text] [Related]
22. [Misuse of literature references in advertising]. Jørgen E Ugeskr Laeger; 2004 Nov; 166(48):4393; author reply 4393-4. PubMed ID: 15587640 [No Abstract] [Full Text] [Related]
23. New inconvenient trend in advertising medicine. Salunke AZ J Indian Med Assoc; 1994 Nov; 92(11):381. PubMed ID: 7890949 [No Abstract] [Full Text] [Related]
24. [The Board for Evaluation of Drug Information: "Cognex clinics" are not popular. Guidelines for a new type of information]. Lakartidningen; 1997 Jan; 94(1-2):32. PubMed ID: 9053600 [No Abstract] [Full Text] [Related]
25. [Direct-to-consumer advertising makes common symptoms a medical issue]. Karlsson Y Lakartidningen; 2001 Nov; 98(48):5525. PubMed ID: 11769368 [No Abstract] [Full Text] [Related]
26. Promoting and advertising therapeutic goods. Trade Practices Commission report on self-regulation. Moulds RF Med J Aust; 1992 Oct; 157(8):513-4. PubMed ID: 1479969 [No Abstract] [Full Text] [Related]
27. [Physicians and patients need more neutral information]. Nord Med; 1974 Jan; 89(1):9-11. PubMed ID: 4819432 [No Abstract] [Full Text] [Related]
28. [Drugs and the public--an example of asymmetrical information]. Hanson J Lakartidningen; 2001 Dec; 98(51-52):5922. PubMed ID: 11806273 [No Abstract] [Full Text] [Related]
33. Lead us not into temptation: drug representatives. Hagan JC Mo Med; 2001 Jul; 98(7):253-4. PubMed ID: 11458712 [No Abstract] [Full Text] [Related]
34. Peddling drugs to docs. Heussner RC Minn Med; 1994 Jun; 77(6):24-31. PubMed ID: 8041331 [No Abstract] [Full Text] [Related]
35. [The inspection of information: "Hidden" comparison, words of evaluation often cause notifications]. Lakartidningen; 1996 Aug; 93(32-33):2763-5. PubMed ID: 8765603 [No Abstract] [Full Text] [Related]
36. More on the pharmaceutical quagmire. Schlemmer JP Fam Med; 1993; 25(7):429-30. PubMed ID: 8292144 [No Abstract] [Full Text] [Related]
37. Educating health professionals about drug and device promotion: a Nepalese perspective. Shankar PR PLoS Med; 2007 Feb; 4(2):e89; author reply e88. PubMed ID: 17326721 [No Abstract] [Full Text] [Related]
38. [Drug companies have to find new indications for ACE inhibitors]. Beermann B Lakartidningen; 1992 Jan; 89(1-2):23. PubMed ID: 1734126 [No Abstract] [Full Text] [Related]
39. [Are drug advertisements of any informative value? Analysis of drug advertisements in the Swedish Medical Journal (Läkartidningen) and the Norwegian Medical Journal (Tidsskrift for Den norske laegeforening) during the first half of 1986]. Stålsby C; Westerholm B Tidsskr Nor Laegeforen; 1987 Jun; 107(17-18):1573-7. PubMed ID: 3603531 [No Abstract] [Full Text] [Related]
40. [Drug treatment of hypercholesterolemia. Confusing discrepancies in guidelines of an advertising campaign]. Bondjers G; Fager G; Wiklund O Lakartidningen; 1990 Jun; 87(25):2171. PubMed ID: 2362508 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]